Susan G. Komen® 2015 Breast Cancer Research Funding Targets Early-Career Investigators, New Therapies, Health Inequities and Metastatic Disease

Grants in 25 States and Eight Countries Sustain Komen Leadership
in Breast Cancer Research

DALLAS–(BUSINESS WIRE)–Susan G. Komen, the world’s largest nonprofit funder of breast cancer
research, announced new grants to 124 researchers in 25 states and eight
countries internationally, with about half of the grants targeted to
early-career researchers squeezed by stagnation in federal research
dollars.


The 2015 research grants expand Komen’s ongoing commitment to funding
early-career scientists, that is, recent graduates and those trying to
establish independent research careers. This group has been hit
especially hard by real-dollar declines of as much as 25 percent in
federal research funding over the past decade.

“We committed two years ago to do all that we can to ensure that
talented early-career investigators remain in the breast cancer research
field, while continuing our support for established researchers,” said
Komen President and CEO Judith A. Salerno, M.D., M.S. “We cannot afford
to lose talented scientists to other fields for lack of funding.”

This year’s research slate brings Komen’s total research investment to
more than $889 million since 1982, the largest of any nonprofit, and
second only to the U.S. government.

Grants from Komen’s nearly $36 million research portfolio – including
more than $17.6 million in grants awarded to early-career investigators
– span the entire cancer continuum from prevention to treatments for
aggressive and metastatic disease. These include:

  • 36 grants to improve understanding of metastatic breast cancer
  • 18 grants investigating how tumors develop drug resistance
  • 19 grants related to the study of triple negative breast cancer
    – one of the most aggressive forms of the disease
  • 15 grants working to identify and understand biological and
    socio-economic health inequities
  • 13 grants seeking to develop new and novel therapies

A
full list of Komen’s 2015 research grants can be found here
.*

In addition to funding breast cancer research, Komen has invested more
than $1.95 billion into community health outreach and global programs
that serve hundreds of thousands of women and men annually through
breast cancer health and support programs that screen, educate and
provide financial, medical and psychosocial assistance.

For more information about Komen’s mission investment, please visit komen.org.

About Susan G. Komen®

Susan G. Komen is the world’s largest breast cancer organization,
funding more breast cancer research than any other nonprofit while
providing real-time help to those facing the disease. Since its founding
in 1982, Komen has funded more than $889 million in research and
provided $1.95 billion in funding to screening, education, treatment and
psychosocial support programs serving millions of people in more than 30
countries worldwide. Komen was founded by Nancy G. Brinker, who promised
her sister, Susan G. Komen, that she would end the disease that claimed
Suzy’s life. Visit komen.org
or call 1-877 GO KOMEN. Connect with us on social at ww5.komen.org/social.

*Contingent upon signed and executed contracts with Komen

Contacts

Susan G. Komen
Andrea Rader, 972-855-4382
press@komen.org